DE69130529D1 - Behandlung von erektionversagen - Google Patents

Behandlung von erektionversagen

Info

Publication number
DE69130529D1
DE69130529D1 DE69130529T DE69130529T DE69130529D1 DE 69130529 D1 DE69130529 D1 DE 69130529D1 DE 69130529 T DE69130529 T DE 69130529T DE 69130529 T DE69130529 T DE 69130529T DE 69130529 D1 DE69130529 D1 DE 69130529D1
Authority
DE
Germany
Prior art keywords
agent
agents include
agents
erectional
failure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69130529T
Other languages
English (en)
Other versions
DE69130529T2 (de
Inventor
Virgil Place
Robert Gale
Randall Berggren
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vivus LLC
Original Assignee
Vivus LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vivus LLC filed Critical Vivus LLC
Application granted granted Critical
Publication of DE69130529D1 publication Critical patent/DE69130529D1/de
Publication of DE69130529T2 publication Critical patent/DE69130529T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F5/00—Orthopaedic methods or devices for non-surgical treatment of bones or joints; Nursing devices; Anti-rape devices
    • A61F5/41—Devices for promoting penis erection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
    • A61M31/002—Devices for releasing a drug at a continuous and controlled rate for a prolonged period of time
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2210/00—Anatomical parts of the body
    • A61M2210/16—Male reproductive, genital organs
    • A61M2210/167—Penis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Reproductive Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Anesthesiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gynecology & Obstetrics (AREA)
  • Nursing (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Vascular Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Reverberation, Karaoke And Other Acoustics (AREA)
  • Professional, Industrial, Or Sporting Protective Garments (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Mechanical Treatment Of Semiconductor (AREA)
  • Biological Treatment Of Waste Water (AREA)
  • Pretreatment Of Seeds And Plants (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
  • Steroid Compounds (AREA)
DE69130529T 1990-04-25 1991-04-22 Behandlung von erektionversagen Expired - Lifetime DE69130529T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US51439790A 1990-04-25 1990-04-25
PCT/US1991/002758 WO1991016021A1 (en) 1990-04-25 1991-04-22 Treatment of erectile dysfunction

Publications (2)

Publication Number Publication Date
DE69130529D1 true DE69130529D1 (de) 1999-01-07
DE69130529T2 DE69130529T2 (de) 1999-06-02

Family

ID=24046960

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69130529T Expired - Lifetime DE69130529T2 (de) 1990-04-25 1991-04-22 Behandlung von erektionversagen

Country Status (16)

Country Link
EP (1) EP0526566B1 (de)
JP (1) JP3477197B2 (de)
KR (1) KR0169950B1 (de)
AT (1) ATE173603T1 (de)
AU (1) AU655420B2 (de)
CA (2) CA2352552C (de)
DE (1) DE69130529T2 (de)
DK (1) DK0526566T3 (de)
ES (1) ES2124225T3 (de)
FI (1) FI104946B (de)
IE (1) IE81089B1 (de)
NO (1) NO300083B1 (de)
NZ (2) NZ237899A (de)
PT (1) PT97441B (de)
WO (1) WO1991016021A1 (de)
ZA (1) ZA912984B (de)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5962528A (en) * 1991-07-03 1999-10-05 Scott; Nathan Earl Prostaglandin E2 /F2α combination for treating impotence
US6291528B1 (en) 1991-07-03 2001-09-18 Nathan Earl Scott Prostaglandin E1/F2 in combination with prostaglandin F2α for enhancing female sexual arousal
US5981593A (en) * 1991-07-03 1999-11-09 Scott; Nathan Earl Prostaglandin E2 treatment of impotence
US5482039A (en) * 1994-03-25 1996-01-09 Vivus, Inc. Process for diagnosing erectile dysfunction, and related methods of treatment
NZ305560A (en) * 1995-03-14 1998-11-25 Vivus Inc Method for preventing erectile dysfunction by administering vasoactive agent, particularly a prostaglandin, kit therefor
US5861431A (en) * 1995-06-07 1999-01-19 Iotek, Inc. Incontinence treatment
US5718917A (en) * 1995-12-15 1998-02-17 Harvard Scientific Corporation PGE-1 containing lyophilized liposomes for use in the treatment of erectile dysfunction
US5855548A (en) * 1996-06-14 1999-01-05 Vivus, Incorporated Venous flow control element for maintaining penile erection
GR1002847B (el) 1997-05-06 1998-01-27 Χρηση της μισοπροστολης ή/και της μισοπροστολης οξυ για την παρασκευη φαρμακευτικου προιοντος για τη θεραπευτικη αντιμετωπιση των δυσλειτουργιων της στυσεως
US6228864B1 (en) 1997-10-28 2001-05-08 Vivus, Inc. Administration of 5-HT receptor agonists and antagonists, to treat premature ejaculation
US5925629A (en) * 1997-10-28 1999-07-20 Vivus, Incorporated Transurethral administration of androgenic agents for the treatment of erectile dysfunction
US5919474A (en) * 1997-10-28 1999-07-06 Vivus, Inc. Transurethral administration of vasoactive agents to treat peripheral vascular disease, related vascular diseases, and vascular impotence associated therewith
US5922341A (en) * 1997-10-28 1999-07-13 Vivus, Incorporated Local administration of pharmacologically active agents to treat premature ejaculation
US6037360A (en) * 1997-10-28 2000-03-14 Vivus, Incorporated Administration of 5-HT3 receptor antagonists to treat premature ejaculation
AU1827299A (en) * 1997-12-18 1999-07-05 Nathan Earl Scott Prostaglandin e2/f2alpha combination for treating impotence and enhancing sexual arousal
ES2155740B1 (es) * 1998-03-31 2001-12-01 Vita Invest Sa Dispositivo intrauretral para el tratamiento de la disfuncion erectil.
CA2251255A1 (en) * 1998-10-20 2000-04-20 Mcgill University The use of dopaminergic agents in the management of sexual dysfunction
AU1414200A (en) * 1998-12-02 2000-06-19 Mochida Pharmaceutical Co., Ltd. Preparations for intraurethral administration
US6825234B2 (en) 1998-12-10 2004-11-30 Nexmed (Holdings) , Inc. Compositions and methods for amelioration of human female sexual dysfunction
US6486207B2 (en) 1998-12-10 2002-11-26 Nexmed (Holdings), Inc. Compositions and methods for amelioration of human female sexual dysfunction
AU3713600A (en) 1999-03-01 2000-09-21 Nitromed, Inc. Nitrosated and nitrosylated prostaglandins, compositions and metods of use
US7105571B2 (en) 2000-01-10 2006-09-12 Nexmed Holdings, Inc. Prostaglandin compositions and methods of treatment for male erectile dysfunction
US6323241B1 (en) 2000-01-10 2001-11-27 Nexmed (Holdings) Inc. Prostaglandin compositions and methods of treatment for male erectile dysfunction
US6693135B2 (en) 2000-01-10 2004-02-17 Nexmed (Holdings) Incorporated Prostaglandin compositions and methods of treatment for male erectile dysfunction
GR1004266B (el) * 2001-04-30 2003-06-18 Ηλιας Κ. Παπαδοπουλος Φαρμακευτικο παρασκευασμα για την διαγνωση και θεραπεια της στυτικης δυσλειτουργιας
NZ579170A (en) 2007-02-12 2012-05-25 Dmi Biosciences Inc Reducing side effects of tramadol
SG174079A1 (en) 2007-02-12 2011-09-29 Dmi Biosciences Inc Treatment of comorbid premature ejaculation and erectile dysfunction
US8465413B2 (en) 2010-11-25 2013-06-18 Coloplast A/S Method of treating Peyronie's disease
AU2016205336A1 (en) 2015-01-06 2017-08-03 Venturis Therapeutics, Inc. Angiogenic treatment of ischemic heart disease
WO2016133848A2 (en) * 2015-02-16 2016-08-25 Cardiovascular Biotherapeutics, Inc. Therapeutic angiogenesis for treating erectile conditions
US10653549B2 (en) * 2017-07-18 2020-05-19 Carl W. Lange, IV Topical medication method for erectile dysfunction
BR102019016950A2 (pt) * 2019-08-15 2021-02-23 Inst De Pesquisa Ensino Ciencia E Tecnologia Aplicada Inst Galzu forma de dosagem intrauretral de medicamento; e dispositivo

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1897423A (en) * 1928-10-30 1933-02-14 Ferri Filiberto Device for preventing gonorrhea infection
US4829991A (en) * 1987-01-06 1989-05-16 Medical Engineering Corp. Method and device for stimulating an erection
US4801587A (en) * 1987-03-02 1989-01-31 Gene Voss Impotence ointment
IT1221826B (it) * 1988-06-08 1990-07-12 Medico Harvey Srl Centro Preparato per uso topico per il trattamento terapeutico dell impotentia coeundi
IL87055A (en) * 1988-07-08 1994-06-24 Illana Gozes Conjugates of vasoactive intestinal peptide (vip) and of fragments thereof and pharmaceutical compositions comprising them
SE463851B (sv) * 1988-09-02 1991-02-04 Amsu Ltd Komposition foer behandling av erektil dysfunktion via uretra
DE3943519A1 (de) * 1989-04-27 1991-01-17 Stief Georg Arzneimittel zur behandlung erektiler dysfunktionen

Also Published As

Publication number Publication date
AU7856391A (en) 1991-11-11
CA2040914A1 (en) 1991-10-26
FI924817A (fi) 1992-10-23
CA2352552C (en) 2008-12-02
JPH05506800A (ja) 1993-10-07
ZA912984B (en) 1992-01-29
CA2352552A1 (en) 1991-10-26
FI924817A0 (fi) 1992-10-23
IE911330A1 (en) 1991-11-06
DE69130529T2 (de) 1999-06-02
PT97441B (pt) 1998-08-31
IE81089B1 (en) 2000-03-08
AU655420B2 (en) 1994-12-22
EP0526566B1 (de) 1998-11-25
KR930700048A (ko) 1993-03-13
NO924032D0 (no) 1992-10-19
KR0169950B1 (ko) 1999-01-15
NO924032L (no) 1992-10-26
NZ270871A (en) 1999-05-28
WO1991016021A1 (en) 1991-10-31
PT97441A (pt) 1992-05-29
ATE173603T1 (de) 1998-12-15
NO300083B1 (no) 1997-04-07
FI104946B (fi) 2000-05-15
JP3477197B2 (ja) 2003-12-10
NZ237899A (en) 1997-03-24
CA2040914C (en) 2001-12-04
ES2124225T3 (es) 1999-02-01
DK0526566T3 (da) 1999-08-09
EP0526566A1 (de) 1993-02-10

Similar Documents

Publication Publication Date Title
DE69130529D1 (de) Behandlung von erektionversagen
KR950002785A (ko) 골량을 증가시키기 위한 부갑상선 호르몬 및 랄옥시펜
SE8803087L (sv) Ett nytt saett foer behandling av erektil dysfunktion
EA200001043A3 (ru) Соединения для лечения женской сексуальной дисфункции
LV12452A (lv) Aktivas vielas vaginala ievadisanas sistema
KR900701282A (ko) 심장 또는 뇌의 허혈성 질환의 치료, 예방제
KR970704429A (ko) 심혈관 질환의 치료를 위한 드롤록시펜의 용도(use of droloxifene for the treatment of cardiovascular diseases)
ATE319447T1 (de) Pharmazeutische zubereitungen die clavulansäure oder derivate enthalten zur behandlund von neurologischen störungen
PT97785A (pt) Metodo para a tratamento da impotencia utilizando, por exemplo, doxazosina
KR920016088A (ko) 하부 요로 질환의 치료
BG105664A (en) Use of apomophines for the treatment of organic erectile dysfunction in males
ATE181236T1 (de) Steigerung des glutathionspiegels durch glutamin
BR9809571A (pt) Composição medicinal e processo para produzì-la
DK0856312T3 (da) Anvendelse af trospiumchlorid til fremstilling af et lægemiddel til behandling af blæresygdomme
KR950016760A (ko) 치질 치료제
KR940703666A (ko) 발기 부전증 치료에 효능있는 약제(a potent drug for treatment of erectile dysfunction)
ATE141506T1 (de) Antineoplastisch wirkender und den antineoplastischen effekt verstärkender wirkstoff
DE69131517D1 (de) Verwendung von Prostaglandin-E1 zur Behandlung männlicher erektiler Impotenz
KR880004810A (ko) 소화성 궤양 치료제
ES2189886T3 (es) Composicion farmaceutica para aplicacion topica.
SE8804640D0 (sv) Medicament comprising cyclolinopeptide a
BR9609868A (pt) Conjugado sintético de uma proteína e uma pluralidade de epítopos para uso em medicina processos para evitar a rejeição de um xenoenxerto ou pelo menos reduzir a extensão ou taxa de rejeição para tratar uma doença e sangue removido de um doador de sangue aparelho sangue composição farmaceuticamente aceitável e uso de um conjugado
KR890007737A (ko) 진토작용을 하는 약제
RU99103105A (ru) Способ лечения вторичной глаукомы
KR930700109A (ko) 신경 질환 치료용 4,4'-[9h-플루오렌-9-일리덴비스(메틸렌)]-비스피리미딘

Legal Events

Date Code Title Description
8327 Change in the person/name/address of the patent owner

Owner name: VIVUS INC., MOUNTAIN VIEW, CALIF., US

8364 No opposition during term of opposition